News
EMA’s human medicine committee recommends approval of GSK’s Blenrep combinations in relapsed/refractory multiple myeloma: London, UK Monday, May 26, 2025, 10:00 Hrs [IST] GSK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback